DAVAO DOCTORS COLLEGE DRUG STUDY

General Malvar St., Davao City Criteria:

Nursing Program Content and organization 40%
Analysis 40% Neatness and
promptness 10% Reference 10 %

Name of the Patient: Stacy De Leon Date of Admission: February 13, 2023 Room: DR-1
Age: 32 years old Sex: Female Civil Status: Married
Attending Physician: Dr. Libres
DRUG NAME CLASSIFICATION / INDICATION CONTRAINDICATION ADVER NURSING
MECHANISM OF S SE RESPONSIBILITY
ACTION EFFECT
Systemic (oral and  CNS: Vertigo, History
Betamethasone parenteral) headache,par (systemic
topical is used administration esthesias, administration):
Corticosteroid (long to treat the insomnia, Infections, fungal
acting) itching, redness, Contraindic seizures, infections,
dryness, ated with psychosis, amebiasis, vaccinia
GENERIC NAME: Glucocorticoid crusting, infections, cataracts, and varicella, and
Bethamethasone scaling, especially increased antibiotic-resistant
Dipropionate Hormone inflammation, tuberculosis, IOP, infections; kidney or
and discomfort fungal glaucoma (in liver disease;
BRAND NAME: Indication: of various skin infections, long-term hypothyroidism;
Bethamethasone, conditions, amebiasis, therapy) ulcerative colitis
Betnelan Systemic including vaccinia and  CV: with impending
administration psoriasis (a skin varicella, and Hypotension, perforation;
disease in which antibiotic- shock, diverticulitis; active
 Hypercalcemi- red, scaly resistant hypertension, or latent peptic
a associated patches form on infections, and CHF ulcer; inflammatory
with cancer some areas of lactation. secondary to bowel disease;
 Short-term the body) and fluid CHF; hypertension;
management eczema (a skin All forms retention, thromboembolic
of disease that thromboembo disorders;
inflammatory causes the skin Use lism, osteoporosis;
to be dry and cautiously with seizure disorders;
ORDERED DOSE: and allergic itchy and to kidney or liver thrombophleb diabetes mellitus;
 12mg IM disorders, sometimes disease, itis, fat lactation
such as develop red, hypothyroidism, embolism,
rheumatoid scaly rashes). ulcerative colitis cardiac Physical:
arthritis, Betamethasone with impending arrhythmias Baseline weight, T,
AVAILABILITY: collagen is in a class of perforation,  Electrolyte reflexes and grip
 TABLET diseases (eg medications diverticulitis, imbalance:N strength, affect and
 VIAL SLE), called active or latent a+ and fluid orientation, P, BP,
 IV BAG dermatologic corticosteroids. peptic ulcer, retention,hyp peripheral
diseases It works by inflammatory okalemia, perfusion,
(egpemphigus activating bowel disease, hypocalcemia prominence of
), status natural CHF,  Endocrine: superficial veins, R
asthmaticus, substances in hypertension, Amenorrhea, and adventitious
and the skin to thromboembolic irregular sounds, serum
autoimmune reduce swelling, disorders, menses, electrolytes, blood
ORDERED disorders redness, and osteoporosis, growth glucose
ROUTE:  Hematologic itching. seizure retardation,
 IM disorders: disorders, decreased
Thrombocytop diabetes carbohydrate
enia purpura, mellitus. tolerance, Interventions
Also possible erythroblastop diabetes
routes: enia . mellitus, Systemic use
 ORAL  Ulcerative cushingoid
 IV colitis, acute state (long- Give daily dose
exacerbations term effect), before 9 AM to
of MS, and increased mimic normal peak
palliation in blood sugar, corticosteroid blood
some increased levels.
leukemias and serum
lymphomas cholesterol, Increase
 Trichinosis decreased T3 dosage when
with and T4 levels, patient is subject to
neurologic or hypothalamic stress.
ORDERED myocardial -pituitary-
FREQUENCY: involvement adrenal Taper doses
(HPA) when discontinuing
Oral suppression
(betametha
sone): Initial  Intra-articular with systemic high-dose or long-
dosage, or soft-tissue therapy term therapy.
0.6– administration. longer than 5
7.2 mg/day  Arthritis, days Do not give live
psoriatic  GI: Peptic or virus vaccines with
IV plaques, and esophageal immunosuppressive
(betametha so forth ulcer, doses of
sone pancreatitis, corticosteroids.
sodium Dermatologic abdominal
phosphate): preparations distention, Topical dermatologic
Initial nausea, preparations
dosage, up  Relief of vomiting,
to 9 mg/day. inflammatory increased Examine area
and pruritic appetite, for infections, skin
manifestations weight gain integrity before
of steroid- (long-term application.
IM responsive therapy)
dermatoses  Musculoskel Administer
(betametha etal: Muscle cautiously to
sone weakness, pregnant patients;
sodium steroid topical
phosphate; myopathy, corticosteroids have
betamethas loss of caused teratogenic
one sodium muscle mass, effects and can be
phosphate osteoporosis, absorbed from
and spontaneous systemic site.
acetate): fractures
Initial (long-term WARNING:
dosage, therapy) Use caution when
0.5–  Other: occlusive dressings
9 mg/day. Immunosuppr or tight diapers
Dosage ession, cover affected area;
range is aggravation, these can increase
one-third to or masking of systemic absorption
one-half infections; of the drug.
oral dose impaired
given q 12 wound
hr. In life-
threatening healing; thin, Avoid
situations, fragile skin; prolonged use near
dose can be petechiae, eyes, in genital and
in multiples ecchymoses, rectal areas, and in
of the oral purpura, skin creases.
dose. striae;
subcutaneou
s fat atrophy;
hypersensitivi Teaching Points
ty or
anaphylactoid Systemic use
reactions
Do not stop
The following taking the oral drug
effects are without consulting
related to various your health care
local routes of provider.
steroid
administration: Take single
dose or alternate-
 Intra- day doses before 9
articular: AM.
Osteonecrosi
s, tendon Avoid
rupture, exposure to
infection infections; ability to
 Intralesional fight infections is
therapy: reduced.
Blindness
when applied Wear a
to fae and medical alert tag so
head emergency care
 Topical providers will know
dermatologi that you are on this
c ointments, medication.
creams,
sprays:Local
burning, You may
irritation,acne experience these
iform lesions, side effects:
striae, skin Increase in
atrophy appetite, weight
gain (counting
calories may help);
heartburn,
indigestion (eat
frequent small
meals; take
antacids); poor
wound healing
(consult with your
care provider);
muscle weakness,
fatigue (frequent
rest periods will
help).

Report unusual
weight gain,
swelling of the
extremities, muscle
weakness, black or
tarry stools, fever,
prolonged sore
throat, colds or
other infections,
worsening of
original disorder.

Intrabursal, intra-articular
therapy
 Do not overuse
joint after therapy,
even if pain is gone.

Topical dermatologic
preparations

Apply
sparingly; do not
cover with tight
dressings.

Avoid contact
with the eyes.

Report irritation
or infection at the
site of application.

REFERENCE:

Davis C. (2019). Bethamethasone Dipropionate (Bethamethasone, Betnelen). Retrieved on February 18, 2023 from
www.medicinenet.com Mims(2020). Mims Drug Handbook Philippines. Retrieved on February 18, 2023 from www.mims.com

Smart Gabrielle L. Cardos St.N

Name of Student